Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2004-07-07
2009-11-17
McIntosh, III, Traviss C (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S049000
Reexamination Certificate
active
07618950
ABSTRACT:
A method for the treatment and prevention of herpes zoster using 5-[(E)-2-halogenovinyl] arabinofuranosyl uracil of the following general formula (1):wherein X represents a halogen atom.
REFERENCES:
patent: 4386076 (1983-05-01), Machida et al.
patent: 5034382 (1991-07-01), Osswald
patent: 6337324 (2002-01-01), Harmenberg et al.
patent: 56-087599 (1981-07-01), None
Wikipedia, definition for “Herpes Zoster”, last updated Sep. 5, 2006.
Diasio et al., “Sorivudine and 5-FU; a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase”, Br. J. Clin. Pharmacol., vol. 46, pp. 1-4, 1998.
Katsushi Ijichi, et al.; “Topical treatment with BV-araU of immunosuppressed and immun ocompetent shaved mice cutaneously infected with herpes simples virus type 1”; Antiviral Research, 21 (1993), pp. 47-57; ©1993 Elsevier Science Publishers B.V.
“Lecture Summaries of the '99 Pharmaceutical Society of Japan, p. 213, 30C10-2”. English-language summary attached, published Jul. 20, 1979.
Lieve Naesens et al., entitled “Recent Developments in Herpesvirus Therapy,” Herpes, 2001, pgs. 12-16, 8:1.
Stephen E. Straus, M.D., entitled “Clinical and Biological Differences Between Recurrent Herpes Simplex Virus and Varicella-Zoster Virus Infections,” JAMA, Dec. 22-29, 1989, pp. 3455-3458, vol. 262, No. 24.
Peter Wutzler, entitled “Antiviral Therapy of Herpes Simplex and Varicella-zoster Virus Infections,” Intervirology 1997, pgs. 343-356, vol. 40.
Erik De Clercq, entitled “Antiviral Drugs in Current Clinical Use,” Journal of Clinical Virology 30, 2004, pp. 115-133.
Machida Haruhiko
Yamamoto Masaichi
aRigen Pharmaceuticals, Inc.
McIntosh, III Traviss C
The Webb Law Firm
LandOfFree
Method for treatment and prevention of herpes zoster by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment and prevention of herpes zoster by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment and prevention of herpes zoster by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4079989